SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Henry Niman who wrote (24168)8/7/1998 11:15:00 PM
From: Cacaito  Respond to of 32384
 
Smithkline in agreement with IMNX on G-CSF patents license to investigate new products. Not only Amgn has a CSF product and patent(they do have about 90% of the market).

Does Smithkline have agreement to developed any CSF product with LGND? if not, Are they working with similar products? Are they just covering some bases before agreement with LGND or anybody else in the subject?

Please, your opinion.